West Cancer Foundation
Board of Directors

Carlton Sedberry

Chief Operating Officer, ImmunoBridge

Carlton Sedberry started his oncology career in 1989 at the West Clinic in Memphis, Tennessee where he established one of the first full-service dedicated in-practice registered pharmacies in the U.S. Under his guidance pharmacy personnel assumed all duties associated with drug purchasing, admixture, payer approval, billing/reimbursement and contracting. He and his team pioneered the use of ambulatory pumps for cancer patients proving their safety and utility in multiple applications of infusion therapy.

Carlton’s diverse background also includes operational and business development experience at Response Oncology, where he served as Executive VP of Development creating a network of 55 multi-disciplined outpatient infusion centers (IMPACT Centers) designed to support a clinical research initiative evaluating ASCT in multiple cancer diagnosis. This initiative was the first corporate effort in the U.S. to provide meaningful comprehensive access to the use of ASCT in community practices through the support of centralized services providing CRO, lab, pharmacy, billing/reimbursement and regulatory expertise for the IMPACT Center staff.

In 2001 as Executive VP with Strategic Oncology Services (SOS), he directed strategic business development and expanded the company’s market research potential. At SOS he applied his understanding of the intricacies of the clinical, operational and financial components of community-based oncology to help design, develop and manage a large national clinically integrated oncology service organization hosting a novel patient data capture platform implemented in over 100 community-based marquee practices. This platform was subsequently used to drive accrual for dozens of cancer clinical trials, conduct large national HEOR studies, design customized data reports that generated in revenue in excess of $10M/year for 5+ years.

While at SOS, in preparation for the Medicare Modernization Act of 2003, Carlton and then CEO of West Clinic, Steve Coplon, collaborated to create the first national association of community-oncology practices now called the Community Oncology Alliance (COA) designed to create the first Political Action Committee (PAC) to represent the interests of community oncologists throughout the U.S. Today, COA provides representation “on the Hill” and a broad range of resources for all levels of the cancer care delivery system including oncologists, hematologists, pharmacists, mid-level providers, oncology nurses, patients, survivors, industry representatives, and even oncology fellows.

As Executive VP of Strategic Development at CancerConsultants.com, from 2004 until 2007, Carlton developed a national oncology network of 250 community practices that delivered a wide variety of internet-based custom patient education and market research initiatives. He has also served as the Managing Director of two community practice-based state oncology associations GPOs with over a billion dollars of annual combined purchases.

In 2007 Carlton brought his 18 years of hands-on experience consulting with large community oncology practices, national oncology networks, oncology-centric GPOs and pharma/biotech clients to MME.

While at MME Carlton has consulted on market access, pricing and commercial development for 200+ oncology-focused agents, diagnostics and medical devices covering the entire spectrum of current therapeutic options (including chemotherapy, supportive care, targeted therapies, radiopharmaceuticals, HSCT, Car-T, tumor-infiltrating lymphocytes and gene-based therapies) while providing expert insight, connectivity with the oncology/hematology marketplace and a working knowledge of the business, technology and science of cancer care.

In 2018 Carlton and several colleagues formed Magnolia Therapeutics, LLC with the intent of applying the experience and expertise learned from over 30 years of hands-on management in cancer care and formal consulting in the pharmaceutical industry to acquire distressed drug assets. Currently, Magnolia has two assets in PII trials and is evaluating a third asset for possible acquisition. Carlton currently serves as the Chief Operating Officer for this organization.

Carlton holds a Doctorate of Pharmacy from the University of Tennessee Center for Health Sciences School of Pharmacy. He frequently moderates oncology/hematology-focused conferences/seminars/advisory boards focused on the science, clinical use, commercialization, pricing and market access of current and new cancer innovations.

Away from work, he actively participates in KAIROS, a national not-for-profit prison ministry, and Epiphany, another national not-for-profit ministry working hand-in-hand with The Juvenile Intervention and Faith-based Follow-Up (JIFF) in Memphis. JIFF provides intensive intervention services to at-risk youth ages 10-18 who are referred through the Memphis and Shelby County Juvenile Court system.